Usefulness of myocardial parametric imaging to evaluate myocardial viability in experimental and in clinical studies

Heart

Volumn 92, Issue 3, 2006, Pages 350-356

  Korosoglou, Grigorios ^a,b   Hansen, A ^b   Bekeredjian, R ^b   Filusch, A ^b   Hardt, S ^b   Wolf, D ^b   Schellberg, D ^b   Katus, H A ^b   Kuecherer, H ^b  

^a Department of Cardiology ^*  (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

SONOVUE;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLINICAL ARTICLE; CLINICAL PRACTICE; CONTRAST ECHOCARDIOGRAPHY; CORONARY ARTERY OBSTRUCTION; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; FEMALE; HEART FUNCTION; HEART MUSCLE BLOOD FLOW; HEART MUSCLE PERFUSION; HUMAN; ISCHEMIC HEART DISEASE; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; MYOCARDIAL PARAMETRIC IMAGING; MYOCARDIAL VIABILITY; NONHUMAN; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SWINE; TISSUE NECROSIS; VISION;

AGED; ANIMALS; CORONARY CIRCULATION; CORONARY STENOSIS; ECHOCARDIOGRAPHY; FEMALE; HUMANS; MALE; MYOCARDIAL ISCHEMIA; OBSERVER VARIATION; PHOSPHOLIPIDS; RISK FACTORS; SULFUR HEXAFLUORIDE; SWINE;

EID: 33644519322     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2005.064246     Document Type: Article

References (26)

1. Galiuto L, DeMaria AN, del Balzo U, et al. Ischemia-reperfusion injury at the microvascular level: treatment by endothelin A-selective antagonist and evaluation by myocardial contrast echocardiography. Circulation 2000;102:3111-6.
2. Hansen A, Kumar A, Wolf D, et al. Evaluation of cardioprotective effects of recombinant soluble P-selectin glycoprotein ligand-Ig in myocardial ischemia-reperfusion injury by real-time myocardial contrast echocardiography. J Am Coll Cardiol 2004;44:887-91.
3. Shimoni S, Frangogiannis NG, Aggeli G, et al. Identification of hibernating myocardium with quantitative intravenous myocardial contrast echocardiography: comparison with dobutamine echocardiography and thallium-201 scintigraphy. Circulation 2003;107:538-44.
4. 18fluordeoxyglucose positron emission tomography and dobutamine stress echocardiography. Am J Cardiol 2004;94:31-7.
5. Korosoglou G, Labadze N, Giannitsis E, et al. Usefulness of real-time myocardial perfusion imaging to evaluate tissue level reperfusion in patients with non-ST-elevation myocardial infarction. Am J Cardiol 2005;95:1033-8.
6. Korosoglou G, Labadze N, Hansen A, et al. Usefulness of real-time myocardial perfusion imaging in the evaluation of patients with first time chest pain. Am J Cardiol 2004;94:1225-31.
7. Korosoglou G, Dubart AE, DaSilva KGC, et al. Real-time myocardial perfusion imaging for pharmacologic stress testing: added value to single-photon emission computed tomography. Am Heart J (in press).
8. Linka AZ, Sklenar J, Wei K, et al. Assessment of transmural distribution of myocardial perfusion with contrast echocardiography. Circulation 1998;98:1912-20.
9. Yu EH, Skyba DM, Leong-Poi H, et al. Incremental value of parametric quantitative assessment of myocardial perfusion by triggered low-power myocardial contrast echocardiography. J Am Coll Cardiol 2004;43:1807-13.
10. Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantification of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr 1989;2:358-67.
11. Pagano D, Bonser RS, Townend JN, et al. Predictive value of dobutamine echocardiography and positron emission tomography in identifying hibernating myocardium in patients with postischaemic heart failure. Heart 1998;79:281-8.
12. Iwanaga S, Ewing SG, Husseini WK, et al. Changes in contractility and afterload have only slight effects on subendocardial systolic flow impediment. Am J Physiol 1995;269:H1202-12.
13. Wei K, Jayaweera AR, Firoozan S, et al. Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion. Circulation 1998;97:473-83.
14. Kramer MS, Feinstein AR. Clinical biostatistics: the biostatistics of concordance. Clin Pharmacol Ther 1981;29:111-23.
15. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet, 1986;i, 307-10.
16. Becher H, Burns PN. Contrast agents for echocardiography: principles and instrumentation. In: Handbook of contrast echocardiograpny. Heidelberg: Springer Verlag, 2000:184.
17. Murthy TH, Li P, Locvicchio E, et al. Real-time myocardial blood flow imaging in normal human beings with the use of myocardial contrast echocardiography. J Am Soc Echocardiogr 2001;14:698-705.
18. Bekeredjian R, Hansen A, Filusch A, et al. Cyclic variation of myocardial signal intensity in real-time myocardial perfusion imaging. J Am Soc Echocardiogr 2002;15:1425-31.
19. Hansen A, Bekeredjian R, Korosoglou G, et al. Fourier phase analysis can be used to objectively analyze real-time myocardial contrast echocardiograms. Int J Cardiovasc Imaging 2004;20:241-8.
20. Ito H, Maruyama A, Iwakura K, et al. Clinical implications of the 'no reflow' phenomenon: a predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. Circulation 1996;93:223-8.
21. Gioia G, Powers J, Heo J, et al. Prognostic value of rest-redistribution tomographic thallium-201 imaging in ischaemic cardiomyopathy. Am J Cardiol 1995;75:759-62.
22. Schlosser T, Pohl C, Kuntz-Hehner S, et al. Echoscintigraphy: a new imaging modality for the reduction of color blooming and acoustic shadowing in contrast sonography. Ultrasound Med Biol 2003;29:985-91.
23. Sabia PJ, Powers ER, Jayaweera AR, et al. An association between collateral blood flow and myocardial viability in patients with recent myocardial infarction. N Engl J Med 1992;327:1825-31.
24. Ragosta M, Camarano G, Kaul S, et al. Microvascular integrity indicates myocellular viability in patients with recent myocardial infarction: new insights using myocardial contrast echocardiography. Circulation 1994;89:2562-9.
25. Pagley PR, Beller GA, Watson DD, et al. Improved outcome after coronary bypass surgery in patients with ischemic cardiomyopathy and residual myocardial viability. Circulation 1997;96:793-800.
26. Lindner JR, Villanueva FS, Dent JM, et al. Assessment of resting perfusion with myocardial contrast echocardiography: theoretical and practical considerations. Am Heart J 2000;139:231-40.